BIO-key International, Inc.
BKYI
$4.55
-$0.09-2.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 97.96% | -30.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 97.96% | -30.06% | |||
| Cost of Revenue | 38.65% | -24.19% | |||
| Gross Profit | 117.77% | -31.83% | |||
| SG&A Expenses | -28.37% | 30.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.59% | 14.45% | |||
| Operating Income | 90.78% | -91.76% | |||
| Income Before Tax | 95.20% | -342.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 95.22% | -344.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 95.22% | -344.57% | |||
| EBIT | 90.78% | -91.76% | |||
| EBITDA | 94.68% | -100.75% | |||
| EPS Basic | 95.71% | -215.10% | |||
| Normalized Basic EPS | 89.61% | -30.23% | |||
| EPS Diluted | 95.71% | -215.10% | |||
| Normalized Diluted EPS | 89.61% | -30.23% | |||
| Average Basic Shares Outstanding | 11.37% | 41.07% | |||
| Average Diluted Shares Outstanding | 11.37% | 41.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||